Article Tools

Search for Related Articles

  • By Author
  • Search In

Announcements

Science Watch logo

JID Article Named "New Hot Paper" by ScienceWatch.com

Dr. Lauri Hicks' 2007 article on pneumococcal disease has been named a "hot new paper" by Thompson Reuters' ScienceWatch.com. Read a Q&A about the article with Dr. Hicks here

Press Release

Unique Collaboration Charts the Migrations of a Parasite that Affected History
Researchers Sequence Louse DNA from Mummies and Propose New Model for its Development


In the News

Featured in Grist
"Another symptom of swine flu: instant amnesia" May 11, 2009
Swine Influenza Virus: Zoonotic Potential and Vaccination Strategies for the Control of Avian and Swine Influenzas
Eileen Thacker and Bruce Janke
Read the veterinary literature on swine flu and you get a strong sense of what might be called vaccination treadmill: the hog industry is literally scrambling to generate new vaccines for the rapidly evolving flu strains that sweep through CAFOs. Writing in the Journal of Infectious Diseases [PDF] in 2008, Eileen Thacker and Bruce Janke of Iowa State University paint a stark picture: “A number of genetically diverse viruses are circulating in swine herds throughout the world and are a major cause of concern to the swine industry,” they write. “Influenza virus infections in swine and poultry are potential sources of viruses for the next pandemic among humans.”

Featured in New York Times
"Fear of a Swine Flu Epidemic in 1976 Offers Some Lessons, and Concerns, Today" May 8, 2009
Anti‐Ganglioside Antibody Induction by Swine (A/NJ/1976/H1N1) and Other Influenza Vaccines: Insights into Vaccine‐Associated Guillain‐Barré Syndrome
Irving Nachamkin, Sean V. Shadomy, Anthony P. Moran, Nancy Cox, Collette Fitzgerald, Huong Ung, Adrian T. Corcoran, John K. Iskander, Lawrence B. Schonberger, and Robert T. Chen
Irving Nachamkin, a professor of pathology and laboratory medicine at the University of Pennsylvania, examined some 1976 vaccine that had been saved by a scientist in Texas. In a paper published last year in The Journal of Infectious Diseases, he and colleagues reported that mice given the vaccine made antibodies that reacted with gangliosides, which are components of nerve cells. An antibody attack on gangliosides is part of the disease mechanism of Guillain-Barré.

Featured in AFP
"Swine flu vaccine 'could be ready soon'" May 7, 2009
A Broadly Protective Vaccine against Globally Dispersed Clade 1 and Clade 2 H5N1 Influenza Viruses
Mary A. Hoelscher, Neetu Singh, Sanjay Garg, Lakshmi Jayashankar, Vic Veguilla, Aseem Pandey, Yumi Matsuoka, Jacqueline M. Katz, Ruben Donis, Suresh K. Mittal, and Suryaprakash Sambhara
The vaccine Mittal created for the bird flu worked on three different strains isolated over a seven-year period and was described in papers for the Journal of Infectious Diseases and the journal Clinical Pharmacology and Therapeutics.

Featured in Newsweek
"The Path of a Pandemic" http://www.newsweek.com/id/195692
Swine Influenza Virus: Zoonotic Potential and Vaccination Strategies for the Control of Avian and Swine Influenzas
Eileen Thacker and Bruce Janke
Last year researchers from Iowa State University in Ames warned that pigs located in industrial-scale farms were being subjected to influenza infections from farm poultry, wild birds and their human handlers. Writing in The Journal of Infectious Diseases, Eileen Thacker and Bruce Janke said, "As a result of the constantly changing genetic makeup of individual influenza viruses in pigs, the U.S. swine industry is continually scrambling to respond to the influenza viruses circulating within individual production systems."

1 November 2007

Volume 196, Number 9
The Journal of Infectious Diseases 2007;196:1369–1378
0022-1899/2007/19609-0016$15.00
DOI: 10.1086/522522
MAJOR ARTICLE

Cross‐Talk between CD31 and the Signaling Lymphocytic Activation Molecule–Associated Protein during Interferon‐γ Production against Mycobacterium tuberculosis

Maria Florencia Quiroga,1,2,a

Javier Oscar Jurado,1,2,a

Gustavo Javier Martínez,1,2

Virginia Pasquinelli,1,2

Rosa María Musella,3

Eduardo Abbate,3

Andrew C. Issekutz,6

María Marta Bracco,4

Alejandro Malbrán,5

Peter Allan Sieling,7

Eduardo Chuluyan,1,2,b and

Verónica Edith García1,2,b

1Department of Microbiology, Parasitology, and Immunology, University of Buenos Aires School of Medicine, 2Laboratorio de Inmunogenética, Hospital de Clínicas José de San Martín, University of Buenos Aires, 3División Tisioneumonología, Hospital FJ Muñiz, 4Instituto de Investigaciones Hematológicas, Academia Nacional de Medicina, 5Departamento de Alergia e Inmunología, Hospital Británico, Buenos Aires, Argentina; 6Department of Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canada; 7Division of Dermatology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, California

Effective host defense against tuberculosis requires Th1 cytokine responses. We studied the regulation of interferon (IFN)‐γ production during tuberculosis by investigating the role of CD31, a receptor that attenuates T cell receptor signals. After antigen stimulation, CD3+CD31+ blood lymphocytes decreased in healthy donors and in tuberculosis patients with robust Th1 responses to Mycobacterium tuberculosis and IFN‐γ was secreted only by CD31 T cells. In contrast, in patients with weak Th1 cytokine responses to M. tuberculosis, the level of CD3+CD31+ lymphocytes was increased and IFN‐γ production was low. Furthermore, the inverse relationship between CD31 expression and IFN‐γ production was in contrast to signaling lymphocytic activation molecule (SLAM) expression, an IFN‐γ inducer in tuberculosis. Interestingly, CD31 bound to SLAM‐associated protein (SAP), an IFN‐γ inhibitor in tuberculosis, and when CD31 and SAP were coexpressed in lymphocytes, their association inhibited the IFN‐γ response to M. tuberculosis. Thus, CD31, when binding to SAP, interferes with Th1 responses, suggesting that CD31 has a key regulatory role in the signaling pathway(s) leading to the IFN‐γ response to M. tuberculosis.

Received 10 March 2007; accepted 22 May 2007; electronically published 26 September 2007.

Reprints or correspondence: Verónica E. García, Dept. of Microbiology, Parasitology, and Immunology, University of Buenos Aires School of Medicine, Paraguay 2155 P.12, Capital Federal, 1121, Buenos Aires, Argentina ().
  • Potential conflicts of interest: none reported.

    Financial support: Agencia Nacional de Promoción Científica y Tecnológica (grant PICT 5‐9638 to V.E.G and grant PICT 15069 E.C.); Antorchas Foundation (support to V.E.G.), University of Buenos Aires (grant UBACyT M030 to V.E.G and grant M09 to E.C.), Consejo Nacional de Investigaciones Científicas y Técnicas (grant PIP 5584 to V.E.G).

  • M.F.Q. and J.O.J. contributed equally to this work.

  • V.E.G and E.C. contributed equally to this work.

Close Popup